Reporting Hemoglobin A1c: Do the Units Matter?
نویسندگان
چکیده
منابع مشابه
Reporting hemoglobin A1c: do the units matter?
Hemoglobin A1c (Hb A1c) 2 is the analyte most commonly measured in clinical laboratories for patients with diabetes mellitus. Physicians use Hb A1c to monitor long-term glycemic control, adjust therapy, and predict complications of diabetes. Recently, Hb A1c was added as a criterion for the diagnosis of diabetes. Unlike most analytes, many patients with diabetes know their Hb A1c value and are ...
متن کاملGlycemic control in the 12 months following a change to SI hemoglobin A1c reporting units.
BACKGROUND Many countries have implemented, or are considering, a change in hemoglobin A1c (Hb A1c) units from traditional percentage values [Diabetes Control and Complications Trial (DCCT)] to the new Système International d'Unités (SI) unit in millimoles per mole. Concern exists that such a large alteration in numeric values might lead, through confusion, to a deterioration in patients' glyce...
متن کاملThe Reporting of Estimated Glucose with Hemoglobin A1c
Hemoglobin A1c (Hb A1c) 2 is a key parameter for understanding glycemic control in diabetes. It is used by both clinicians and patients to trigger adjustments in behavior and treatment. In general, clinicians understand Hb A1c and its limitations well, but evidence suggests that patients have difficulty understanding what Hb A1c means and how it relates to glucose. This situation may be particu...
متن کاملThe Reporting of Estimated Glucose with Hemoglobin A1c
Healthcare providers and patients with diabetes evaluate the efficacy of glycemic control by 2 strategies. One strategy involves self-monitoring of blood glucose (SMBG) by patients, with portable meters and continuous blood glucose monitors or sensing devices. Patients use these glucose values for daily decisionmaking to adjust medication doses and/or modify food intake or exercise regimens. Bl...
متن کاملPoint: The reporting of estimated glucose with hemoglobin A1c.
Healthcare providers and patients with diabetes evaluate the efficacy of glycemic control by 2 strategies. One strategy involves self-monitoring of blood glucose (SMBG) by patients, with portable meters and continuous blood glucose monitors or sensing devices. Patients use these glucose values for daily decisionmaking to adjust medication doses and/or modify food intake or exercise regimens. Bl...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Chemistry
سال: 2013
ISSN: 0009-9147,1530-8561
DOI: 10.1373/clinchem.2013.211227